- Home
- NRO vs TIL Comparison
NRO vs TIL Comparison
Compare NRO & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- TIL
- Stock Information
- Founded
- NRO 2003
- TIL 2018
- Country
- NRO United States
- TIL United States
- Employees
- NRO N/A
- TIL N/A
- Industry
- NRO Finance/Investors Services
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- NRO Finance
- TIL Health Care
- Exchange
- NRO Nasdaq
- TIL Nasdaq
- Market Cap
- NRO 156.7M
- TIL 177.1M
- IPO Year
- NRO N/A
- TIL 2021
- Fundamental
- Price
- NRO $3.20
- TIL $18.43
- Analyst Decision
- NRO
- TIL Strong Buy
- Analyst Count
- NRO 0
- TIL 5
- Target Price
- NRO N/A
- TIL $100.67
- AVG Volume (30 Days)
- NRO 239.4K
- TIL 184.6K
- Earning Date
- NRO 01-01-0001
- TIL 11-12-2025
- Dividend Yield
- NRO 11.41%
- TIL N/A
- EPS Growth
- NRO N/A
- TIL N/A
- EPS
- NRO N/A
- TIL N/A
- Revenue
- NRO N/A
- TIL N/A
- Revenue This Year
- NRO N/A
- TIL N/A
- Revenue Next Year
- NRO N/A
- TIL N/A
- P/E Ratio
- NRO N/A
- TIL N/A
- Revenue Growth
- NRO N/A
- TIL N/A
- 52 Week Low
- NRO $2.51
- TIL $10.80
- 52 Week High
- NRO $3.45
- TIL $48.60
- Technical
- Relative Strength Index (RSI)
- NRO 41.43
- TIL 40.22
- Support Level
- NRO $3.23
- TIL $17.38
- Resistance Level
- NRO $3.28
- TIL $19.50
- Average True Range (ATR)
- NRO 0.03
- TIL 1.60
- MACD
- NRO -0.01
- TIL 0.04
- Stochastic Oscillator
- NRO 13.64
- TIL 34.90
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.